Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Candida can be implicated in the pathology of chronic periodontitis.
Aims: To analyze the oral Candida carriage in patients suffering from chronic periodontitis (CP) and its correlation with the severity of this condition.
Methods: Microbiological samples were taken from 155 patients using the oral rinse (OR) technique and by using paper points in the periodontal pockets (GPP). These patients were divided into 3 groups: 89 patients without CP (control), 47 with moderate CP, and 19 with severe CP. Samples were cultured in a Candida chromogenic agar for Candida. Species were identified by microbiological and molecular methods.
Results: Candida was isolated in the OR of 45 (50.6%), 21 (44.7%), and 11 (57.9%) patients, respectively, and in the GPP of 32 (36%), 14 (29.2%), and 10 (42.6%) patients from the control, moderate CP and severe CP groups, respectively. Candida was isolated more frequently and in a greater burden in OR than in GPP (p<0.01). Candida albicans was the most prevalent species. GPP of patients with CP had poor fungal biodiversity (p<0.01).
Conclusions: Colonization by Candida was present in the samples of patients without CP, and with both moderate and severe CP. Nonetheless, patients with severe CP had a higher rate of Candida colonization, especially by C. albicans.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.riam.2018.03.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Role of in chronic inflammation and the development of oral squamous cell carcinoma.
Cancer Pathog Ther
September 2025
Department of Microbiology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, 603203, Tamil Nadu, India.
Oral cancer pathogenesis is significantly influenced by species, especially , through chronic inflammation and cellular dysregulation. Epidemiological studies highlight a strong correlation between persistent infections and oral carcinogenesis. Experimental evidence has identified key biomolecular mechanisms, including biofilm formation, epithelial invasion, and immune evasion.
View Article and Find Full Text PDFThe Effect of 6-Week Advanced Oral Care on Oral Microbiome and Mycobiome Composition in People With Dementia Living in Residential Aged Care.
Clin Exp Dent Res
October 2025
Tasmanian School of Medicine, College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia.
Objectives: Oral health is an important aspect of quality of life for older people, especially those with dementia. The impact of an active oral hygiene program on the oral microbiome was explored in a group of older participants (average age 84 years old) with dementia against a separate control group whose oral hygiene followed the status quo.
Materials And Methods: The oral cavity bacteriomes and mycobiomes were assessed from swabs of cheek, gum, and tongue surfaces.
Enzymatic and mechanical disruption before successive photodynamic therapy targets the extracellular matrix of Candida albicans.
Photodiagnosis Photodyn Ther
September 2025
Laboratory of Applied Microbiology Department of Dental Materials and Prosthodontics, Universidade Estadual Paulista "Júlio de Mesquita Filho", Faculdade de Odontologia de Araraquara, Araraquara, SP, Brazil. Electronic address:
Objective: To evaluate whether pretreatment strategies targeting the extracellular matrix (ECM), such as DNase I and low-frequency ultrasound, enhance the efficacy of successive antimicrobial photodynamic therapy (aPDT) against Candida albicans biofilms and to assess the effects on biofilm components.
Methods: Forty-eight-hour C. albicans (ATCC 90028) biofilms were treated under four conditions: (I) aPDT [Photodithazine (PDZ) (25 mg/L) for 20 min + Light-Emitting Diode (LED) (660 nm, 18 J/cm²)], (II) DNase+aPDT [5 min with 20 U/mL DNase I before aPDT], (III) sonication+aPDT [7 W, 170-190 J before aPDT], (IV) Dn+So+aPDT.
Utilization of intravenous posaconazole in pediatric patients undergoing hematopoietic stem cell transplant.
Transplant Cell Ther
September 2025
Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Background: Pediatric patients undergoing hematopoietic stem cell transplant (HSCT) are at high risk for fungal infections including Candida, Aspergillus, and Mucorales necessitating the use of broad-spectrum antifungal agents such as posaconazole for prophylaxis and at times for treatment of invasive fungal infections. When first approved, posaconazole was limited to an immediate release oral suspension, which exhibited unreliable absorption dependent on co-administration with high fat meals. During HSCT, patients commonly have significant nausea, vomiting, and decreased enteral intake making this formulation particularly challenging.
View Article and Find Full Text PDFChemical characterization and antimicrobial activities of Citrus aurantifolia peel oils and Ocimum sanctum ethanolic extract.
PLoS One
September 2025
Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand.
Oral diseases affect more than 3.5 billion people globally, representing a major public health burden, particularly in low- and middle-income countries where access to dental care is often limited. Furthermore, the use of conventional antimicrobial agent may cause side effect.
View Article and Find Full Text PDF